| Literature DB >> 25460001 |
David Gurwitz1, Elena Milanesi2, Thomas Koenig3.
Abstract
Entities:
Mesh:
Year: 2014 PMID: 25460001 PMCID: PMC4251823 DOI: 10.1371/journal.pbio.1002010
Source DB: PubMed Journal: PLoS Biol ISSN: 1544-9173 Impact factor: 8.029
Major public funding agencies, annual funding levels, application success rates, and published details of the assessment process.
| Agency ( | Total annual funding (million US$) | Success rate biomedical/life sciences | Abstract | Funding | Assessment summary | Final report |
|
| 30100 | 14% (Medical research, 2012) | Yes | Yes | No | No |
|
| 7170 | 22% (General, 2013) | Yes | Yes | No | No |
|
| 3945 | 25% (General, 2012–2013) | No | Yes | No | No |
|
| 3171 | 30.3% (General, 2012) | Yes | Yes | No | Yes |
|
| 3160 | 28.3% (Life Sciences) | Yes | No | No | No |
|
| 2976 | 16.9% (Health Science, 2011) 20.9% (Life Sciences, 2011) | Yes | Yes | No | No |
|
| 2150 | 12% | Yes | Yes | No | No |
|
| 1357 | 21.6% (2013–2014) | Yes | Yes | No | No |
|
| 937 | NR | No | Yes | No | No |
|
| 933 | NR for Biomedical/Life Sciences | No | Yes | No | No |
|
| 894 | NR | No | No | No | No |
|
| 789 | 50% | No | No | No | No |
|
| 777 | 27% | Yes | Yes | No | No |
|
| 748 | 20.5% | Yes | Yes | No | Yes |
|
| 691 | NR | Yes | Yes | No | No |
|
| 548 | 16.5% (General) | Yes | Yes | No | No |
|
| 395 | 17% (Health research, 2012) | Yes | Yes | No | No |
|
| 364 | NR | Yes | Yes | No | No |
|
| 302 | 22% (Life Sciences) | No | Yes | No | No |
|
| 258 | 30.2% (General, 2012) | Yes | No | No | No |
|
| 225 | 36.9%-38.2% (2011) | No | No | No | No |
|
| 205 | 23% (Medical science); 19% (General) | Yes | Yes | No | No |
|
| 200 |
| Yes | No | No | Yes |
|
| 171 |
| No | Yes | No | No |
|
| 163 | 42.8% | Yes | Yes | No | Yes |
|
| 136 | 32.8% (General) | No | Yes | No | No |
|
| 117 | 9% | Yes | No | No | No |
*Arranged by decreasing total annual funding.
Funding levels and success rates are the latest as available on the funding agencies websites on October 10. 2014, rounded to nearest million US$ according to exchange rates on that day. NR: not reported.
Knowledge items.
| Item | Knowledge category |
|
| Rules |
|
| Rules |
|
| Content |
|
| Content |
|
| Content |
|
| Content |
|
| Expertise |
|
| Expertise |
|
| Expertise |
|
| Produce |
|
| Produce |
|
| Produce |
|
| Produce |
Recommended incremental transparency measures.
| Item | Should this item be published? |
|
| Yes |
|
| Yes |
|
| No |
|
| Yes, in aggregated form, following the selection process |
|
| No |
|
| No |
|
| Yes |
|
| Yes, only for funded proposals |
|
| Yes |
|
| Yes |
|
| Yes |
*Starred items may be considered as radical transparency measures; at this time we deem it premature to recommend their open publication by default but would welcome small-scale experimentation in this area.